Fungal infections - candida Flashcards

(39 cards)

1
Q

types of infections associated with candida

A

muscosal - orpharyngeal, esophageal, vulvovaginitis
candidemia
invasive (acute disseminated) - involves visceral sites/orgnas
hepatosplenic (chronic disseminated) - most commun in hematologic malignency with recent neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common species

A
albicans - 50% 
glabrata 
parapsilosis - catheters
tropicalis 
krusei
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what makes someone more likely to be infected with non albicans

A

fluconazole prophylaxis/preemptive use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

c.auris is what

A

emerging health care associated multi drug resistant pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk factors for candidiasis

A
ICU  >4days
septic shock 
liver transplant 
peritoneal dialysis related peritonitis 
severe pancreatitis 
GI surgery particularly if associated with a leak 
IC esp hematologic malignancy, chemo, transplant, corticosteroids
central venous catheter
broad spectrum antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bassis for diagnosing candidiasis

A

culture- triazole susceptibility
microscopic examination - budding yeast with hyphae = candida
histology critical for deep seated infections, particularly mold
PCR - 90%spec/sens but lacks standardization
beta d-glucan - non specific cell wall component, flase negatives
mass spectrometry - 4 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe the skin lesions and additional diagnostic

A

pustules on a red base

scrape sample or punch biopsy for histopathology and culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

a patient with hepatosplenic micro abscesses presents with

A

RQ pain
persistent fever
increased alkaline phosphatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe endopthalmitis and additional diagnosistics

A

choroid and retina with fluffly yellow white lesions, viritis, or retinal hemorrhages
funduscopic eye exams indicated in candidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the prognosis of candidemia

A

30-40% mortality
directly related to the speed of getting treatment
>3x with a 12-24 hour delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the likely source of candidemia in non neutropenic patients

A

central venous catheter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the likely source of candidemia in neutropenic patients

A

GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

first antifungal therapy for candidemia in non neutropenic patients

A

echiocandin
dosing the same as given
iv only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

antifungal therapy for candidemia in non critically ill non invasive and without risk factors for fluconazole r

A

fluconazole 88mg load

400mg q24hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

alternative for candidemia in non neutropenic patients in pregnancy, allergy, intolerance

A

amphotericin B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when would you consider step down to fluconazole 400 q24 for candidemia non neutropenic

A

5-7 days if symptoms resolved and clinically stable
flucon susceptible isolate
negative repeat blood culture (cultures should be taken every 1-2d)

17
Q

duration of treatment for candidemia non neutropenic

A

2 weeks after negative repeat blood culture

18
Q

what might you consider in candidemia in patients with persistent infection and prolonged neutropenia

A

granulocyte colony stimulatin factors

granulocyte infusions

19
Q

antifungal therapy for candidemia in neutropenic

20
Q

alternative for candidemia in neutropenic patients in pregnancy, resistance, intolerance

A

amphotericin b

21
Q

what do you use for non critically ill non invasive without risk factors for flucon R in candidemia neutropenic patients

A

fluconazole 800mg load 400mg q24hr

22
Q

why is static cautioned in neutropenic patients

A

static relies on the patients immune system to kill the bug and in these patients the number of WBC is decreased

23
Q

what can you use as additional fungal/mold coverage in candidemia neutropenic

A

voriconazole

same dose as in chart higher end

24
Q

duration of therapy in candidemia neutropenic

A

2 weeks past negative blood culture, symptoms resolve, and neutropenia resolved (ANC>500)

25
considerations when treating c.glabrate
dose dependent antifungal activity | increasign fluconR
26
treatment for c.glabrata
``` echinocandin alternatives: (use the high dose) amphoB fluconazole voriconazole (no better more AE) ```
27
considerations for treating c.krusei
intrinsically flucon-R | relatively high amphoB MICs
28
treatment for c.krusei
echinocandin alternatives: voriconazole if susceptible high dose amphoB
29
what is the purpose of having amphotericin as a liposomal drug
to decrease the neprotoxicity of the drug but then decreases the amount of free drug have to increase the dose so really not that effective
30
a way to avoid nephrotoxicity of amphotericin b
give as continuous infusion
31
special considerations in treating invasive candidiasis
prompt aggresive | prolonged
32
treatment of infections in the eye
fluconazole treatment of choice | echinocandins dont penetrate the eye fluid
33
who gets empirical antifungal therapy for candidiasis
persistent fever despite broad spectrum antibiotics in high risk patient based on preliminary microbiology or histopathology or plasma b-d-glucan
34
who are high risk patients
``` critically ill in ICU neutropenic fever IC total parenteral nutrition recent GI surgery candida colonization ```
35
empirical antifungal therapy options
echinocandin fluconazole - fluconazole naive, colonized with susceptible candida alternative: amphoB
36
approved candidiasis indication for fluconazole
oropharyngeal esophageal invasive prophylaxis
37
approved candidiasis indications for itraconazole
oropharyngeal | esophageal candidiasis
38
candidiasis indications for voriconazole
esophageal | invasive
39
posaconazole indications for candidiasis
oropharyngeal | prophylaxis